Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 19.23 billion as of September 9, 2025. Its market cap has increased by 44.65% in one year.

Market Cap

19.23B

Enterprise Value

19.09B

Revenue

3.62B

Ranking

n/a

PE Ratio

45.34

Stock Price

1,905.05

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 19.23B, an increase of 1,999.44%. That is a compound annual growth rate of 47.18%.

Market Cap History

Date	Market Cap	% Change
Sep 8, 2025	19.23B	-0.43%
Dec 31, 2024	19.31B	36.67%
Dec 29, 2023	14.13B	107.04%
Dec 30, 2022	6.83B	10.89%
Dec 31, 2021	6.16B	497.76%
Dec 31, 2020	1.03B	56.85%
Dec 27, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Oct 25, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	18.61T
HDFC Bank	14.79T
Bharti Airtel	11.37T
Tata Consultancy Services	11.03T
ICICI Bank	10.02T
State Bank of India	7,445.42B
Hindustan Unilever	6,187.41B
Infosys	5,988.26B

Market Cap Rankings